| Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study T Marjot, AM Moon, JA Cook, S Abd-Elsalam, C Aloman, MJ Armstrong, ... Journal of hepatology 74 (3), 567-577, 2021 | 496 | 2021 |
| High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry AM Moon, GJ Webb, C Aloman, MJ Armstrong, T Cargill, R Dhanasekaran, ... Journal of hepatology 73 (3), 705-708, 2020 | 318 | 2020 |
| Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study GJ Webb, T Marjot, JA Cook, C Aloman, MJ Armstrong, EJ Brenner, ... The lancet Gastroenterology & hepatology 5 (11), 1008-1016, 2020 | 253 | 2020 |
| Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study D Kim, N Adeniji, N Latt, S Kumar, PP Bloom, ES Aby, P Perumalswami, ... Clinical Gastroenterology and Hepatology 19 (7), 1469-1479. e19, 2021 | 217 | 2021 |
| Prevalence of chronic hepatitis B virus infection in the United States JK Lim, MH Nguyen, WR Kim, R Gish, P Perumalswami, IM Jacobson Official journal of the American College of Gastroenterology| ACG 115 (9 …, 2020 | 153 | 2020 |
| Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions EJ Bini, PV Perumalswami Hepatology 51 (3), 759-766, 2010 | 108 | 2010 |
| COVID-19 in liver transplant recipients: an initial experience from the US epicenter BT Lee, PV Perumalswami, GY Im, S Florman, TD Schiano, BL Da, ... Gastroenterology 159 (3), 1176-1178. e2, 2020 | 95 | 2020 |
| Liver stiffness decreases rapidly in response to successful hepatitis C treatment and then plateaus S Chekuri, J Nickerson, K Bichoupan, R Sefcik, K Doobay, S Chang, ... PloS one 11 (7), e0159413, 2016 | 93 | 2016 |
| Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection P Perumalswami, DE Kleiner, G Lutchman, T Heller, B Borg, Y Park, ... Hepatology 43 (4), 780-787, 2006 | 90 | 2006 |
| Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID‐19): US multicenter experience A Rabiee, B Sadowski, N Adeniji, PV Perumalswami, V Nguyen, A Moghe, ... Hepatology 72 (6), 1900-1911, 2020 | 81 | 2020 |
| Pregnancy-related liver diseases C Pan, PV Perumalswami Clinics in liver disease 15 (1), 199-208, 2011 | 79 | 2011 |
| Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities PV Perumalswami, SH Factor, L Kapelusznik, SL Friedman, CQ Pan, ... Journal of hepatology 58 (5), 890-897, 2013 | 73 | 2013 |
| Liver injury in patients hospitalized with coronavirus disease 2019 correlates with hyperinflammatory response and elevated Interleukin‐6 BL Da, T Kushner, M El Halabi, P Paka, M Khalid, A Uberoi, BT Lee, ... Hepatology communications 5 (2), 177-188, 2021 | 51 | 2021 |
| Costs of telaprevir‐based triple therapy for hepatitis C: $189,000 per sustained virological response K Bichoupan, V Martel‐Laferriere, D Sachs, M Ng, EA Schonfeld, ... Hepatology 60 (4), 1187-1195, 2014 | 50 | 2014 |
| A novel collaborative community-based hepatitis B screening and linkage to care program for African immigrants H Shankar, D Blanas, K Bichoupan, D Ndiaye, E Carmody, ... Clinical Infectious Diseases 62 (suppl_4), S289-S297, 2016 | 46 | 2016 |
| Adapting the Andersen model to a francophone West African immigrant population: hepatitis B screening and linkage to care in New York City DA Blanas, K Nichols, M Bekele, H Shankar, S Bekele, L Jandorf, ... Journal of community health 40, 175-184, 2015 | 43 | 2015 |
| Vaccination as a triggering event for autoimmune hepatitis P Perumalswami, L Peng, JA Odin Seminars in liver disease 29 (03), 331-334, 2009 | 43 | 2009 |
| Factors related to hepatitis B screening among Africans in New York City P Sriphanlop, L Jandorf, C Kairouz, L Thelemaque, H Shankar, ... American Journal of Health Behavior 38 (5), 745-754, 2014 | 41 | 2014 |
| A systematic model improves hepatitis C virus birth cohort screening in hospital‐based primary care A Goel, J Sanchez, L Paulino, C Feuille, J Arend, B Shah, D Dieterich, ... Journal of viral hepatitis 24 (6), 477-485, 2017 | 37 | 2017 |
| Virological response rates for telaprevir‐based hepatitis C triple therapy in patients with and without HIV coinfection V Martel‐Laferrière, S Brinkley, K Bichoupan, S Posner, A Stivala, ... HIV medicine 15 (2), 108-115, 2014 | 35 | 2014 |
